BCL2 and ovarian cancer: Several other ARE-binding proteins have also been identified to stabilize BCL2. For example, ζ-crystallin, TRA2β (transformer 2β), and LARP1 (La-related protein 1) have been shown to stabilize BCL2 and enhance BCL2 expression in T cell acute lymphocytic leukemia, colon cancers, and ovarian cancers, respectively [81,82,83].